Valneva raises EUR 45M

Valneva SE (Euronext:VLA; VSE:VLA) raised EUR 45 million ($51 million) through the sale of 18.2 million shares at EUR 2.47 in a rights offering underwritten by Credit Agricole and Kempen & Co.

The company is acquiring Crucell Sweden AB, which will give it rights to Dukoral, a vaccine against cholera and travelers' diarrhea, as well as commercial infrastructure to distribute vaccines in the Nordic region. ...